4.5 Article

The impact of infections on reimbursement in 92 US hospitals, 2015-2018

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Immunology

Antibiotic Development Incentives That Reflect Societal Value of Antibiotics

Helen W. Boucher et al.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities

Katherine E. Goodman et al.

Summary: This study aimed to compare different models for risk-adjusting antibiotic utilization, and found that incorporating patient clinical data related to appropriate antibiotic use significantly improved antibiotic utilization predictions and had a substantial impact on hospital utilization rankings.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States

Richard E. Nelson et al.

Summary: This study estimated the healthcare costs associated with infections due to multidrug-resistant bacteria in the United States, revealing that these infections resulted in substantial healthcare costs.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect?

Cornelius J. Clancy et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis

Shruti K. Gadre et al.

Article Infectious Diseases

Antimicrobial stewardship during a time of rapid antimicrobial development: Potential impact on industry for future investment

Lucas T. Schulz et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)

Editorial Material Medicine, General & Internal

Sustainable Discovery and Development of Antibiotics - Is a Nonprofit Approach the Future?

Travis B. Nielsen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Letter Biotechnology & Applied Microbiology

A shot in the arm for new antibiotics

Kevin Outterson

NATURE BIOTECHNOLOGY (2019)

Article Health Care Sciences & Services

Antibiotic-Resistant Infection Treatment Costs Have Doubled Since 2002, Now Exceeding $2 Billion Annually

Kenneth E. Thorpe et al.

HEALTH AFFAIRS (2018)

Article Ethics

A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All

Taimur Bhatti et al.

JOURNAL OF LAW MEDICINE & ETHICS (2018)

Article Public, Environmental & Occupational Health

Performance characteristics and associated outcomes for an automated surveillance tool for bloodstream infection

Jessica P. Ridgway et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2016)

Article Health Care Sciences & Services

Repairing The Broken Market For Antibiotic Innovation

Kevin Outterson et al.

HEALTH AFFAIRS (2015)